• 1
    Vakil N, Van Zanten S, Kahrilas P, et al. The Montreal Definition and Classification of GERD: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 190020.
    Direct Link:
  • 2
    Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 7107.
  • 3
    Coffin LA. The relationship of upper airway passages to diseases of gastrointestinal tract. Ann Otol Rhinol Laryngol 1903; 12: 5216.
  • 4
    Cherry J, Margulies SI. Contact ulcer of the larynx. Laryngoscope 1968; 78: 193740.
  • 5
    Ohman L, Olofsson J, Tibbling L. Esophageal dysfunction in patients with contact ulcer of the larynx. Ann Otol Rhinol Laryngol 1978; 92: 22830.
  • 6
    Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101(Suppl. 53): 178.
  • 7
    Wong RKH, Hanson DG, Waring PJ, et al. ENT manifestations of gastroesophageal reflux. Am J Gastroenterol 2000; 95(Suppl.): S1522.
  • 8
    Wilson JA, White A, Von Haacke NP, et al. Gastroesophageal reflux and posterior laryngitis. Ann Otol Rhinol Laryngol 1989; 98: 40510.
  • 9
    Koufman J. Gastroesophageal reflux disease in otolaryngology. Laryngoscope 1991; 101(Suppl.): 178.
  • 10
    Nostrant TT. Gastroesophageal reflux and laryngitis: a skeptic's view. Am J Med 2000; 108(4A): 149S52S.
  • 11
    Richter JE. Review article: extra-oesophageal manifestations of gastro-oesophageal disease. Aliment Pharmacol Ther 2005; 22(Suppl. I): 7080.
  • 12
    Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896900.
  • 13
    HigginsJPT, GreenS (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. (accessed 31st May 2005).
  • 14
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 15
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 16
    Newcombe RG, Altman DG. Proportion and their differences. In: AltmanDG, MachinD, TrevorNB, NewcombeRG, eds. Statistics with Confidences, 2nd edn. London: BMJ Books, 2000: 4556.
  • 17
    Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 62934.
  • 18
    Altman DG. Confidence interval for number need to treat. BMJ 1998; 317: 130912.
  • 19
    Eherer AJ, Habermann W, Hammer HF, et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003; 38: 4627.
  • 20
    El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 97983.
    Direct Link:
  • 21
    Ours TM, Kavuru MS, Schilz RJ, et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 31318.
    Direct Link:
  • 22
    Steward DL, Wilson KM, Kelly DH, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004; 131: 34250.
  • 23
    Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006; 116: 25460.
  • 24
    Vaezi MF, Douglas M, Hicks M, et al. A randomized, double-blind, placebo-controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux. Gastroenterology 2004; 126: 160.
  • 25
    Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the Reflux Symptom Index (RSI). J Voice 2002; 16: 2747.
  • 26
    Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the Reflux Finding Score (RFS). Laryngoscope 2001; 111: 13137.
  • 27
    Johnson DA, Schechter GL, Katz P, et al. ENT and GI specialists interpretation of possible reflux laryngitis-coalition or confusion? Gastroenterology 1992; 102: A91.
  • 28
    Milstein CF, Charbel S, Hicks DM, et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope 2005; 115: 225661.
  • 29
    Richter J. Ambulatory esophageal pH monitoring. Am J Med 1997; 103(Suppl. 5A): 130S4S.
  • 30
    Wiener G, Koufman J, Wu W, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-hr ambulatory pH monitoring. Am J Gastroenterol 1989; 84: 15038.
  • 31
    Williams RBH, Galib NA, Wallace KL, et al. Esophagopharyngeal acid regurgitation: dual pH monitoring criteria for its detection and insight into mechanisms. Gastroenterology 1999; 117: 105161.
  • 32
    Ahmed TF, Kwandwala F, Abelson TI, et al. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol 2006; 101: 4708.
    Direct Link:
  • 33
    Moayyedi P. Can we mix apples and oranges? Am J Gastroenterol 2004; 99: 2297301.
    Direct Link:
  • 34
    Thompson SG and Higgins JPT. How should meta-regression analyses be undertaken and interpreted?. Stat Med 2002; 21: 155973.